Recorded: February 27, 2021
In this informative webinar, Anisha Dua, MD, MPH, Northwestern University Feinberg School of Medicine moderates a discussion on the most current information about COVID-19 and the vaccine rollout.
Dr. Dua is joined by Dr. Peter A. Merkel, Professor of Medicine and Epidemiology University of Pennsylvania Chief, Division of Rheumatology, and Dr. Divi Cornec, Professor of Rheumatology at Brest University Hospital in Brest, Brittany, France.
The panelists discuss the vaccines, the latest trending models of the virus, and other relevant topics for patients with vasculitis.
|Welcome and Introductions||01:04|
|A COVID-19 Update||03:14|
|Impact of COVID-19 on Patients Living with Vasculitis Survey Report||07:01|
|Vasculitis Community’s Feelings on the Flu and COVID-19 Vaccine Report||09:29|
|Question: Is there a situation where you would advise a patient with vasculitis to not get the COVID-19 vaccine?||15:38|
|Question: Should I hold my Methotrexate treatment if I’m also getting the COVID-19 vaccine?||18:59|
|Question: What about the timing between my rituximab infusion and when I get the vaccine?||21:45|
|Question: Should I still wear a mask even after I get the vaccine?||28:53|
|Question: Are there any concerns about the use of MRNA technology and as opposed to other vaccine delivery platforms?||33:27|
|Question: Is there any advantage of getting one type of vaccine over another one?||37:35|
|Question: Have these vaccines been tested on patients with vasculitis?||41:38|
|Question: Should I get an antibody test for COVID-19?||42:43|